7*24 Hotline：
The pharmaceutical industry Co., Ltd. of Guoyao group was formerly China pharmaceutical company. On December 21, 1999, it was founded and initiated by China Pharmaceutical Group. In November 2002, the company was listed on the Shanghai Stock Exchange (Stock Code: 600511), with a registered capital of RMB 766.93 million. Sinopharm is affiliated to China's largest drug and health care product distributor, China Pharmaceutical Holding Co., Ltd., and is a third-level subsidiary of China Pharmaceutical Group. Focusing on the core position of "specialty brand of characteristic pharmaceutical and health industry", Sinopharm shares has been deeply cultivated in Beijing regional market, radiating the national pharmaceutical market, and has 11 wholly-owned or holding subsidiaries and 4 participating companies. Its business forms include pharmaceutical business, pharmaceutical industry, logistics warehouse storage, import bonded and other businesses. Meanwhile, with the help of capital driven and innovation driven, the upstream and downstream industrial chain is extended to lay out the national characteristic large health care market. In 2017, China Pharmaceutical Co., Ltd. realized a revenue of 36.3 billion yuan, ranking the first wholesale enterprise in the pharmaceutical circulation industry in Beijing.
oil wellhead